Personalized medicine: Lung Cancer leads the way
Authors:
- 1 April 2013
- journal article
- editorial
- Published by Wolters Kluwer Health in Indian Journal of Cancer
- Vol. 50 (2) , 77-79
Abstract
The Indian Journal of Cancer is an official publication of the Indian Cancer Society and Indian Society of Oncology.Keywords
This publication has 15 references indexed in Scilit:
- Molecular epidemiology of epidermal growth factor receptor mutations in lung cancers in Indian populationIndian Journal of Cancer, 2013
- Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in IndiaIndian Journal of Cancer, 2013
- A year of anaplastic large cell kinase testing for lung carcinoma: Pathological and technical perspectivesIndian Journal of Cancer, 2013
- What is the true prevalence of EGFR mutations in India?Lung Cancer, 2011
- Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After ChemotherapyJournal of Clinical Oncology, 2011
- Screening for EGFR mutations in lung cancer, a report from IndiaLung Cancer, 2011
- Clinical Experience with Gefitinib in Indian PatientsJournal of Thoracic Oncology, 2008
- Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2006
- Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL StudyJournal of Thoracic Oncology, 2006
- Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)The Lancet, 2005